Clinical Trial

Chronic Myeloid Leukemia (CML) Real-Life Database

Recruiting
View on ClinicalTrials.gov →
Summary
Establish the largest possible real-life cohort collecting long-term follow-up of a maximum number of CML patients in order to carry out observational studies: epidemiological, identification of subgroups according to their response to treatment, evaluation of new molecules in real life, therapeutic discontinuations, impact of the evolution of recommendations, etc.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-07-18.
Trial Details
NCT Number NCT05963061
Lead Sponsor University Hospital, Clermont-Ferrand
Collaborators: Centre Hospitalier Universitaire de Saint Etienne, Bicetre Hospital, University Hospital, Caen, Central Hospital, Nancy, France, University Hospital, Toulouse, CH Annecy Genevois, Rennes University Hospital, Hopital Paul Brousse, Versailles Hospital, Centre Hospitalier Emile Roux, University Hospital, Limoges, Institut Paoli-Calmettes, Centre Hospitalier de Rochefort
Conditions Chronic Myeloid Leukemia (CML)
Enrollment 3,500 participants
Start Date 2014-04-16
Primary Completion 2034-04-16 (estimated)
Study Completion 2034-04-16 (estimated)
Updated on ClinicalTrials.gov 2024-04-09